How much funding has Galixir raised?

Galixir has raised $10.0M in total funding, most recently a Seed round.

Who are Galixir's investors?

Galixir's investors include Oui Capital, 5Y Capital, IMO Ventures, BAI capital, Redpoint China, Neon.

Where is Galixir headquartered?

Galixir is headquartered in Beijing, China.

What industry is Galixir in?

Galixir operates in Artificial Intelligence, Biotech.

Galixir

Beijing, China · Founded 2019 · $10.0M raised

Artificial Intelligence

Biotech

Headquarters: Beijing
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: galixir.com
Total Funding: $10.0M
Last Round: $10.0M SeedAug 2020
Rounds: 3

About

Galixir, founded in 2019, is dedicated to employing cutting-edge artificial intelligence (AI) technologies to accelerate drug research and development. By leveraging its AI algorithms and organically integrating computational chemistry and medicinal chemistry, Galixir optimizes preclinical R&D processes by providing high-quality drug candidates and cutting time and costs, increasing the overall probability of product launch. Collaborating with pharmaceutical companies and institutions globally, Galixir is advancing its drug discovery pipelines for multiple indications using Pyxir, its proprietary AIDD platform.

Summary

Galixir is an Artificial Intelligence company based in Beijing, China, founded in 2019. It has raised $10.0M in total across 3 rounds, most recently a $10.0M Seed round in Aug 2020. Investors include Oui Capital, 5Y Capital and IMO Ventures.